Us Federal Trade Commission
Recent News About Us Federal Trade Commission View More
-
Feds: Company used bots to snag tens of thousands of tickets, made $9M reselling
BROOKLYN, N.Y. (Legal Newsline) – The federal government is suing Just In Time Tickets, claiming the company are using bots to scoop up tens of thousands of tickets for resale. -
NutraClick settles marketing lawsuit by FTC for $1M
LOS ANGELES (Legal Newsline) – The Federal Trade Commission has settled with a company called NutraClick over allegations it violated a four-year-old court order.NutraClick, also known as Force Factor, will pay $1.04 million to settle the FTC’s recently filed lawsuit, it was announced Sept. 22. -
Trial lawyers start search for next big mass tort, increase Zantac ads by more than 1,000%
Recent advertising figures indicate the makers of the heartburn drug Zantac and its generic equivalents will soon be facing an onslaught of lawsuits, as personal injury lawyers have begun the process of rounding up clients. -
Here are the names of lawyers whose TV ads are scaring and lying to viewers, according to the FTC
WASHINGTON (Legal Newsline) – The Federal Trade Commission says lawyers and legal advertisers looking for plaintiffs to sue drug companies are making false claims in their TV ads, as well as possibly scaring viewers into stopping taking their medications. -
Scaremongering lawyers should be disciplined
Lawyers running anti-drug commercials should be held accountable for their claims. If they can’t substantiate those claims, they should be forced to compensate the companies whose sales they’ve depressed and the drug users whose health they’ve impaired. -
Millions are spent on ads targeting diabetes medications, but FTC worried lawyers are lying in them
WASHINGTON (Legal Newsline) – As a federal agency considers whether lawyers are illegally frightening potential clients who see their television commercials, research shows drugs like Invokana and Truvada are among the most popular subjects of lawyer spending. -
FTC reaches settlement in first case regarding dietary supplement 'fake paid reviews'
WASHINGTON (Legal Newsline). — The Federal Trade Commission (FTC) has reached a settlement in its first-ever case regarding a dietary supplement manufacturer's alleged use of "fake paid reviews" to market a weight-loss supplement. -
FTC settles with operators of alleged work-from-home scam
WASHINGTON (Legal Newsline) — The Federal Trade Commission (FTC) announced Feb. 14 that it has reached a settlement with two men who allegedly made several million dollars from customers by conducting a "work-from home business opportunity" scam. -
FTC reaches settlement on $1.1 billion joint venture between three PET manufacturers
WASHINGTON, D.C. — A $1.1 billion joint venture between three polyethylene terephthalate resin (PET) manufacturers, which the federal government charged would violate antitrust laws, has been restructured as part of a settlement with the Federal Trade Commission (FTC). -
Administrative judge upholds FTC allegations on merger of 2 chloride titanium dioxide suppliers
WASHINGTON, D.C. — The Federal Trade Commission's (FTC) allegations that a $1.67 merger between two chloride process titanium dioxide suppliers would affect competition in that market was recently upheld by an administrative law judge. -
FTC reaches agreement with industrial gas suppliers involved in $80 billion merger
WASHINGTON, D.C. — Charges by the federal government that an $80 billion merger of industrial gas suppliers Praxair Inc. and Linde AG would violate antitrust laws have been settled with an agreement by the companies to divest assets as a public comment period begins on the divesture. -
FTC reaches $63.5 million settlement with marketers of alleged 'get rich with Amazon' scheme
WASHINGTON, D.C. —The Federal Trade Commission (FTC) has reached a $63.5 million settlement agreement with marketers accused of running a "get rich with Amazon" scheme that caused consumers to lose money and their ability to sell on amazon.com as well as other problems with Amazon stores. -
New Jersey company settles FTC charges of false claims regarding mosquito repellent
WASHINGTON, D.C. — The Federal Trade Commission (FTC) has approved a consent order that settles charges against a New Jersey company of using deceptive marketing to allege its products repel mosquitoes carrying the Zika virus and other diseases. -
U.S. reaches settlement with companies over alleged Privacy Shield violations
WASHINGTON, D.C. — The federal government has reached a settlement with four companies accused of falsely claiming participation in the EU-U.S. Privacy Shield, with two of the companies allegedly failing to abide by the Privacy Shield requirements. -
FTC: Mobile phone manufacturer deceived customers over disclosure of data security
WASHINGTON, D.C. — The Federal Trade Commission has reached a final settlement with a mobile phone manufacturer to resolve the agency's charges that the company deceived customers about data security practices and disclosure of their personal information. -
U.S. reaches settlement in alleged multimillion dollar business coaching scheme
WASHINGTON, D.C. — A federal agency has reached a settlement with one of the defendants in a multimillion dollar business coaching scheme that allegedly involved telling customers they could earn a six-figure salary within 90 days. -
FTC OKs multinational convenience store operator's divestiture of two Minnesota fuel stations
WASHINGTON, D.C. — A Canadian multinational convenience store operator, Alimentation Couche-Tard Inc., (ACT) has reached a settlement and received approval with the U.S. federal government to divest two retail fuel stations in Minnesota. -
AbbVie files appeal contesting landmark $448 million antitrust win for Federal Trade Commission
PHILADELPHIA (Legal Newsline) — Defendants AbbVie Inc., Abbott Laboratories and Unimed Pharmaceuticals LLC filed an appeal on Aug. 6 in a U.S. District Court in response to the final judgment in an antitrust case that found in favor of the Federal Trade Commission.
